Cresco Labs Inc. (CRLBF)
(Delayed Data from OTC)
$1.05 USD
-0.05 (-4.55%)
Updated Dec 4, 2024 03:59 PM ET
4-Sell of 5 4
B Value A Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
03/21/2025
Time: -- |
12/2024 | $-0.02 | -33.33% |
Earnings Summary
For their last quarter, Cresco Labs Inc. (CRLBF) reported earnings of -$0.02 per share, missing the Zacks Consensus Estimate of -$0.01 per share. This reflects a negative earnings surprise of 100.00%. Look out for CRLBF's next earnings release expected on March 21, 2025. For the next earning release, we expect the company to report earnings of -$0.02 per share, reflecting a year-over-year decrease of 300%.
Earnings History
Price & Consensus
Zacks News for CRLBF
AtriCure (ATRC) Reports Q2 Loss, Lags Revenue Estimates
CRLBF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Universal Health Services (UHS) Q2 Earnings and Revenues Surpass Estimates
QuidelOrtho (QDEL) Q1 Earnings and Revenues Top Estimates
Will Cresco Labs Inc. (CRLBF) Report Negative Earnings Next Week? What You Should Know
CRLBF FAQs
Cresco Labs Inc. (CRLBF) has announced they will report their next quarter earnings on March 21, 2025. For the next earning release, we expect the company to report earnings of $-0.02 per share, reflecting a year-over-year decrease of -300.00%.
Cresco Labs Inc. has announced they will report their previous quarter earnings after the close of the market on March 21, 2025.
The Zacks Consensus Estimate for Cresco Labs Inc. (CRLBF) for the quarter ending in December 2024 is $-0.02 a share. We expect Cresco Labs Inc. to miss by -33.33%.
In the earnings report for the quarter ending in June 2024, Cresco Labs Inc. (CRLBF) announced earnings of $-0.16 per share versus the Zacks Consensus Estimate of $-0.01 per share, representing a surprise of #######%.